| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/05/2003 | EP1280566A2 Growth factor modified protein matrices for tissue engineering |
| 02/05/2003 | EP1280557A1 Method for the preparation of polymeric micelle via phase separation of block copolymer |
| 02/05/2003 | EP1280553A2 Methods of affecting laminin 5 processing |
| 02/05/2003 | EP1280552A2 Compositions and methods of treating cancer using compositions comprising an inhibitor of endothelin receptor activity |
| 02/05/2003 | EP1280549A2 Use of urokinase inhibitors for the treatment and/or prevention of pulmonary hypertension and/or cardiac remodelling |
| 02/05/2003 | EP1280548A2 Subcutaneous administration of cagulation factor vii |
| 02/05/2003 | EP1280547A2 Mast cell regulation |
| 02/05/2003 | EP1280546A1 Method and composition for the treatment of angiogenesis |
| 02/05/2003 | EP1280540A1 Modified factor viii |
| 02/05/2003 | EP1280539A2 Nontoxic vernix compositions and method of producing |
| 02/05/2003 | EP1280533A2 Aldosterone antagonist composition for release during aldosterone acrophase |
| 02/05/2003 | EP1280531A1 Local anesthetic methods and kits |
| 02/05/2003 | EP1280521A2 Vaccine composition, method of preparing the same, and method of vaccinating vertebrates |
| 02/05/2003 | EP1280520A2 Phospholipid-based powders for drug delivery |
| 02/05/2003 | EP1280518A2 Liposome drug delivery |
| 02/05/2003 | EP1280516A1 Method for transdermal or intradermal delivery of molecules |
| 02/05/2003 | EP1280512A2 Delivery systems for treatment of vascular disease |
| 02/05/2003 | EP1280511A1 Stabilised enzyme compositions |
| 02/05/2003 | EP1280409A1 A gene therapy system and method using alpha-msh and its derivatives |
| 02/05/2003 | EP1280406A1 Vaccines, immunotherapeutics and methods for using the same |
| 02/05/2003 | EP1200101A4 Methods for transdifferentiation of body tissues |
| 02/05/2003 | EP1196187A4 Keratinocyte growth factor-2 formulations |
| 02/05/2003 | EP0909178B1 Interleukin-8 as an antiviral and antitumor agent |
| 02/05/2003 | EP0871463B1 Regulation of eating behavior |
| 02/05/2003 | EP0819760B1 Process for producing phosphatidylserines having polybasic unsaturated fatty acid as side chain |
| 02/05/2003 | EP0574512B1 Redirection of cellular immunity by receptor chimeras |
| 02/05/2003 | CN1395580A Human cystine knot polypeptide |
| 02/05/2003 | CN1395490A Antigen-specific IgE antibody production inhibitors |
| 02/05/2003 | CN1394962A Method for producing human brain-derived neurotrophic factor NDNF by using methanol yeast (pichia pastoris) and its application |
| 02/05/2003 | CN1394960A Method for producing neurotrophon-3 (NT-3) by using methanol yeast (pichia pastoris) and its application |
| 02/05/2003 | CN1394956A Human epidermal growth factor receptor specific fusion protein and its application |
| 02/05/2003 | CN1394954A Fusion protein with function of resisting tumor and its application |
| 02/05/2003 | CN1394874A Human thio-oxidizing proteinoid gene and three-D space structure of its coded protein and physiologic function |
| 02/05/2003 | CN1394873A Human calcium ion/calmodulin dependent protein kinase II inhibitory protein and its application |
| 02/05/2003 | CN1394872A Gene clone of host cell proteinoid and biological function of its protein |
| 02/05/2003 | CN1394871A Staphylococcus aureus virulence stimulating factor inhibiting peptide and its application |
| 02/05/2003 | CN1394648A Recombinant basic fibroblast growth factor protection agent |
| 02/05/2003 | CN1394647A Shuning gel propellant injection preparation |
| 02/05/2003 | CN1394646A Anticancer Chinese medicine powder preparation and its preparation method |
| 02/05/2003 | CN1100788C Peptide for vaccine of schistosomiasis |
| 02/05/2003 | CN1100787C Peptide for vaccine of schisosomiasis |
| 02/05/2003 | CN1100785C 1,3,4,5-tetrahydrobenzo [c] azepin-3-one disulfide derivative and method |
| 02/05/2003 | CN1100567C Health-care enzymatic chitosan food |
| 02/05/2003 | CN1100566C Medicinal composition containing calcineurin phosphatase B subunit |
| 02/05/2003 | CN1100565C Interferon ointment and its preparation method |
| 02/05/2003 | CN1100564C Medicine for treating HIV infection, its composition and its use |
| 02/05/2003 | CN1100542C Compositions containing at least one glucocoricoid in combination with pulmonary surfactant for treatment of IRDS and ARDS |
| 02/04/2003 | US6515173 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/04/2003 | US6515170 Enzymatic oxidative deamination process |
| 02/04/2003 | US6515119 Use of S-ydcB and B-ydcB, essential bacterial genes |
| 02/04/2003 | US6515118 DNA fragmentation factor |
| 02/04/2003 | US6515106 Modified T4 bacteriophage polypeptide with antibiotic, anti-viral, anti-cancer activity; has antibiotic activity without exhibiting muramidase (lysozyme) activity; use in veterinary/ human medicine, plant disease resistance; food preservation |
| 02/04/2003 | US6515105 Vascular Endothelial Growth Factor binding to extracellular domain of NP-1 (Neuropilin-1); bioactive complexes; mediate useful cell responses or antagonize undesired biological activities; angiogenesis; cell differentiation |
| 02/04/2003 | US6515104 Therapeutic peptide-based constructs derived from domain II of bactericidal/permeability-increasing protein |
| 02/04/2003 | US6515103 Polypeptides naturally occurring in venom of cone snails; include gamma-carboxyglutamic acid; use as anticonvulsant, neuroprotective, and pain management agents |
| 02/04/2003 | US6515011 Anticoagulants |
| 02/04/2003 | US6514980 Nucleoside analogs in combination therapy of herpes simplex infections |
| 02/04/2003 | US6514978 Compounds such as 1-(n-(2-(amidinoaminooxy)ethyl)amino) carbonylmethyl-6-methyl-3-(phenethylamino)-pyrazinone attached to a polymer coated onto a medical device for blood collection or storage; antiagglomerants |
| 02/04/2003 | US6514955 An agent in an amount effective to cause blood glutathione levels to increase, antioxidants at a dose higher than the recommended daily minimum requirement; and nuclear factor kappa B (NFKB) induction inhibitor |
| 02/04/2003 | US6514953 Calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate |
| 02/04/2003 | US6514952 For the treatment and prophylaxis of diseases which are caused by an undesired extent of leucocyte adhesion and/or leucocyte migration such as rheumatoid arthritis or allergic disorders |
| 02/04/2003 | US6514942 Nonapeptide induces Her-2 peptide reactive cytotoxic T-lymphocytes |
| 02/04/2003 | US6514941 Solubilizing casein in an aqueous solvent and hydrolyzing the solubilized casein with an agent (e.g., a protease) that does not cleave the C6, C7 and C12 peptides, resulting hydrolysate is fractionated |
| 02/04/2003 | US6514940 Protected during pasteurization stabilizers (monosaccharides, disaccharides, and oligosaccharides; or amino acids) |
| 02/04/2003 | US6514939 Mutants of atrial natriuretic factor that are protective for stroke |
| 02/04/2003 | US6514938 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 02/04/2003 | US6514937 Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3 |
| 02/04/2003 | US6514936 Antiviral methods using human rhinovirus receptor (ICAM-1) |
| 02/04/2003 | US6514935 Methods of treating hypertension |
| 02/04/2003 | US6514934 For treating sexual dysfunctions in males and females |
| 02/04/2003 | US6514761 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases |
| 02/04/2003 | US6514758 Methods for treatment of HIV and other infections using A T cell or viral activator and anti-retroviral combination therapy |
| 02/04/2003 | US6514756 Human myoblast cell lines and their uses |
| 02/04/2003 | US6514754 Of herpesvirus of turkeys (HVT) inserted in a non-essential region of the vector; may be manipulated to provide vaccines |
| 02/04/2003 | US6514753 Expression vectors for producing modified proteins |
| 02/04/2003 | US6514752 Homologous recombination for universal donor cells and chimeric mammalian hosts |
| 02/04/2003 | US6514745 Oncoprotein protein kinase |
| 02/04/2003 | US6514729 Recombinant interferon-beta muteins |
| 02/04/2003 | US6514727 Isolated nucleic acid molecule encoding a cyclic peptide having amino acids linked by peptide bonds and interchain crosslinks. |
| 02/04/2003 | US6514726 Aspergillus fumigatus acetyl coenzyme-A carboxylase genes and polypeptides and uses thereof |
| 02/04/2003 | US6514724 Isolated polynucleotide encoding a polypeptide which has high binding affinity. |
| 02/04/2003 | US6514715 Genetic engineering; detecting binding |
| 02/04/2003 | US6514712 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas |
| 02/04/2003 | US6514710 Method of using cyclic peptides to inhibit binding to urokinase-type plasminogen activator receptor |
| 02/04/2003 | US6514701 Antimicrobial peptides and methods of use thereof |
| 02/04/2003 | US6514697 Methods for detection of Crytosporidium species and isolates and for diagnosis of Cryptosporidium infections |
| 02/04/2003 | US6514696 Detection thereof; Using polynucleotide that hybridizes to given nucleotide sequence; Cancer |
| 02/04/2003 | US6514695 Compositions and methods for intraductal gene therapy |
| 02/04/2003 | US6514692 Method for treatment of immunodeficiency virus infection |
| 02/04/2003 | US6514691 An antigenic envelope polypeptide of given amino acid sequence was identified |
| 02/04/2003 | US6514686 Alzheimer's disease |
| 02/04/2003 | US6514685 Detection of cancer using antibodies to the alphafeto protein receptor |
| 02/04/2003 | US6514533 Device for the sustained release of aggregation-stabilized, biologically active agent |
| 02/04/2003 | US6514526 Coated starch capsules and a process for producing them |
| 02/04/2003 | US6514513 Costimulatory blockade and mixed chimerism in transplantation |
| 02/04/2003 | US6514506 Melanin-degrading enzyme extract; twice as effective as kojic acid |
| 02/04/2003 | US6514500 Long lasting synthetic glucagon like peptide {GLP-!} |
| 02/04/2003 | US6514499 Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof |
| 02/04/2003 | US6514498 Modified/chimeric superantigens and their use |
| 02/04/2003 | US6514497 Inhibition of LERK-2-mediated cell adhesion |